Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$1.97 - $4.21 $123,712 - $264,379
62,798 New
62,798 $256,000
Q2 2022

Jul 29, 2022

SELL
$4.74 - $8.15 $61,477 - $105,705
-12,970 Closed
0 $0
Q3 2021

Oct 25, 2021

SELL
$13.71 - $17.18 $42,501 - $53,258
-3,100 Reduced 19.29%
12,970 $185,000
Q1 2021

Apr 26, 2021

BUY
$7.33 - $21.06 $117,793 - $338,434
16,070 New
16,070 $293,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $406M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.